Publication | Open Access
A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis
144
Citations
16
References
2007
Year
InflammationAnti-inflammatoryAutoimmune DiseaseImmunologyGastroenterologyPathologyUlcerative ColitisImmunotherapyMedicineRheumatoid Arthritis
| Year | Citations | |
|---|---|---|
Page 1
Page 1